About Index Trending news
Analyze
Pricing
GSK

GSK

Work at GSK? Add yourself to this profile

GSK

We’re a science-led global healthcare company on a mission to help people to do more, feel better, live longer. Twitter code of conduct on our site
Edit Profile
More info

Elsewhere

Also headquartered in London

Reuters Reuters Blockchain Blockchain BBC BBC Vodafone Vodafone SwiftKey SwiftKey Ubuntu Ubuntu Virgin Virgin Volkswagen Volkswagen Charlie Charlie Deliveroo Deliveroo

Companies in the same industry

Prexton Therapeutics SA Prexton Therapeutics SA Bioquark Inc. Bioquark Inc. Bristol-Myers Squibb Bristol-Myers Squibb Chantest Chantest Genomera Genomera Pearl Therapeutics Pearl Therapeutics Esperion Therapeutics Esperion Therapeutics Hyasynth Bio Hyasynth Bio Thar Pharmaceuticals Thar Pharmaceuticals Polyneuron Polyneuron

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 6

Portfolio

Portfolio tracker

Apps 55
Add info

Investment profile

Target markets
Health and Wellness Health Care Biotechnology Pharmaceuticals

Activity

Past year's investments

GlaxoSmithKline participated in fewer than 3 rounds over the past year.

Latest rounds

- ZappRx: Venture capital (Series A) ($5.6M)
- Ionis Pharma: Venture capital ($11M)
- SetPoint Medical: Venture capital (Series A) ($30.6M)

Main Co-investors

- SR One

ZappRx

ZappRx

Health Care
Total funding
$32.6M in 4 rounds from 14 investors
By GlaxoSmithKline
$5.6M Series A in Apr, 2015
SetPoint Medical

SetPoint Medical

Medical +1
Total funding
$115.9M in 7 rounds from 18 investors
By GlaxoSmithKline
$30.6M Series A in Aug, 2013
Robert Gould

Robert Gould

Health and Wellness +1
Total funding
$43.5M in 3 rounds from 7 investors
By GlaxoSmithKline
$4M Venture capital in Oct, 2011
Ionis Pharma

Ionis Pharma

Biotechnology
Total funding
$11M in 1 rounds from 1 investors
By GlaxoSmithKline
$11M Venture capital in Jul, 2014
Theravance

Theravance

Biotechnology
Total funding
$129.4M in 1 rounds from 1 investors
By GlaxoSmithKline
$129.4M Private equity in Nov, 2010

Want to see the complete list?
Go Pro!